The Pharmaceutical Industry has a diverse set of products all with varying level of microbial risk to patients. On the low risk extreme there are topical pharmaceuticals on the other extreme are the ...

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" ...

Note: This article is based on the white paper "Establishing Bioburden Alert and Action Levels" available for download. Most national and international standards regarding bioburden, sterilization, or ...

Methods to Simultaneously Reduce Bioburden and Maintain Column Integrity, Explained Continuous bioprocessing is inevitably becoming the future of biomanufacturing. To date, several steps within a ...

Marketresearch.biz reports that the Bioburden Testing Market size is expected to be worth around USD 4.93 Billion by 2033, from USD 1.35 Billion in 2023, growing at a CAGR of 14.20% during the ...

Merck has launched its latest pharmaceutical bioburden and water testing product, the Milliflex Oasis® System. The system had 96 new features, which are designed to provide benefits such as: ...

Marketresearch.biz reports that the Rising investments by companies on R&D in lifesciences and increasing product recalls due to microbial contamination are other factors driving growth of the target ...

As biopharma companies fine-tune their strategies for continuous bioprocessing, bioburden control has become a top priority. The approaches that worked for batch processing are inadequate for ...

In a recent press release, Tru-D announced a study published in the American Journal of Infection Control, Ultraviolet-C light as a means of disinfection anesthesia workstations, which demonstrated ...